North Wales, PA, United States of America

Mark Andrew Youngman

USPTO Granted Patents = 42 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 18 (Patent Applications = 14)

Average Co-Inventor Count = 3.7

ph-index = 11

Forward Citations = 286(Granted Patents)

Location History:

Warminster, PA (US) (2000 - 2013)
Spring House, PA (US) (2012 - 2014)
North Wales, PA (US) (2011 - 2021)

Company Filing History:

Janssen Pharmaceutica Nv

patents

6 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

4. 1 out of 32

Janssen Pharmaceutica

patents

5. 1 out of 13

Johnson & Johnson Pharmaceutical Research & Development, LLC

patents

6. 2 out of 832,843

Other

patents

Years Active: 2000-2021

Loading Chart...

Areas of Expertise:

Azaspiro Derivatives

Sodium Channel Blockers

Morphinan Analogs

Opioid Receptor Modulators

Pyrimidine Carboxamides

Spirocyclic Morphinans

TRPM8 Modulators

Cold Menthol Receptor Antagonists

Vanilloid VR1 Receptor

Bradykinin Receptor Modulators

Neuropeptide Y Receptor Inhibitors

Obesity Treatment

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11180502 - Azaspiro[4.5]decane derivatives and use thereof (2021-11-23),

2. 10774050 - Pyrimidines as sodium channel blockers (2020-09-15),

3. 10550088 - 6-substituted and 7-substituted morphinan analogs and the use thereof (2020-02-04),

4. 10196364 - Pyrimidine carboxamides as sodium channel blockers (2019-02-05),

5. 10131666 - Heterocyclic morphinan derivatives and use thereof (2018-11-20),

6. 10059675 - Pyrimidines as sodium channel blockers (2018-08-28),

7. 10030021 - Spirocyclic morphinans and use thereof (2018-07-24),

8. 9902726 - Pyridone-sulfone morphinan analogs as opioid receptor ligands (2018-02-27),

9. 9884865 - Azaspiro[4.5] decane derivatives and use thereof (2018-02-06),

10. 9862726 - Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans (2018-01-09),

11. 9714252 - Cyclic sulfonamides as sodium channel blockers (2017-07-25),

12. 9656968 - Pyrimidines as sodium channel blockers (2017-05-23),

13. 9656959 - Substituted pyridines as sodium channel blockers (2017-05-23),

14. 9637458 - Pyrimidine carboxamides as sodium channel blockers (2017-05-02),

15. 9434711 - Sulfonamides as TRPM8 modulators (2016-09-06),

Title: The Innovative Journey of Mark Andrew Youngman

Introduction:

Mark Andrew Youngman, a visionary inventor hailing from North Wales, PA (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents:

Mark Andrew Youngman's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for residential use, and a medical device aimed at improving patient care and outcomes.

Career Highlights:

With a background in engineering and a passion for innovation, Mark Andrew Youngman has successfully brought numerous ideas from concept to reality. His career highlights include receiving multiple awards for his inventions, being featured in prestigious tech magazines, and delivering TED talks on the importance of creativity in technology.

Collaborations:

Throughout his career, Mark Andrew Youngman has collaborated with leading tech companies, research institutions, and universities to further develop his inventions. His collaborative spirit and dedication to pushing the boundaries of technology have led to successful partnerships and groundbreaking innovations.

Conclusion:

In conclusion, Mark Andrew Youngman's relentless pursuit of innovation and his commitment to making a positive impact on society through his inventions make him a true pioneer in the field of technology. His work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.